A. Mäkelburg

Different risk of deep vein thrombosis and pulmonary embolism in carriers with factor V Leiden compared with non-carriers, but not in other thrombophilic defects. Results from a large retrospective family cohort study

M. Prins, H. Büller, K. Hamulýak, 2010, Haematologica.

Active cytomegalovirus infection in patients with acute venous thrombosis: A case‐control study

H. Kluin-Nelemans, H. Sprenger, W. Lijfering, 2011, American journal of hematology.

Occurrence of FVIII Inhibitors in Hemophilia A Patients Following an Institutional Switch to a Third Generation B-Domain-Deleted FVIII

K. Meijer, M. Lukens, R. Tamminga, 2023, Clinical and applied thrombosis/hemostasis.

On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patients.

D. Hommes, C. Mulder, D. D. de Jong, 2005, World journal of gastroenterology.

Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia.

J. Binnekade, P. Tuinman, B. Biemond, 2023, The New England journal of medicine.

Vemurafenib-Induced Disseminated Intravascular Coagulation in Metastatic Melanoma.

E. D. de Vries, G. Hospers, C. Schröder, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Low absolute risk of venous and arterial thrombosis in hyperhomocysteinaemia – A prospective family cohort study in asymptomatic subjects

M. Prins, H. Büller, S. Middeldorp, 2008, Thrombosis and Haemostasis.

Different risk of deep vein thrombosis and pulmonary embolism in carriers with factor V Leiden compared with non-carriers, but not in other thrombophilic defects. Results from a large retrospective family cohort study

M. Prins, H. Büller, S. Middeldorp, 2010, Haematologica.